What this study is
Suicide in youth is rapidly growing to where it is the second leading cause of death across the United States. Use of available tools have shown the potential to boost primary care providers' (PCPs) detection of suicide risk and confidence and knowledge around addressing it; however, ways that work to address clinic and provider barriers that influence the ongoing implementation of a pathway to manage at-risk patients remain under researched. The proposed study will assess the impact of the investigators Facilitated Suicide Prevention program--which provides support to assist practices in integrating screening, assessment, data analysis and management procedures into routine care through feedback and coaching--on clinic use of the suicide prevention pathway and youth suicide.
The project hypothesizes that compared to PCPs in Training Only (TO) practices, those in TO+Practice Facilitation (PF) may rate the care pathway as more able to be carried out and acceptable; demonstrate greater use of the pathway components (screening, risk assessment, safety planning, lethal means safety counseling, referrals and follow-up); demonstrate higher levels of use of the pathway suicide prevention skills ; and report higher levels of confidence putting the care pathway into use.
Also we predict that, compared to youth who screen positive for suicide risk and are followed by PCPs in TO practices, those who screen positive and are followed by PCPs in TO+PF practices will be less likely to attempt suicide during the next six months; less likely to have suicidal ideation during the next 6 months; more likely to see a behavioral health provider during the next 6 months; and less likely to be sent to Emergency Departments during the next 6 months .
What's being tested
- Practice Facilitation
Intervention · OTHER
Practice facilitation (PF) is a supplemental support to increase competence and and adoption of the National Institute of Mental Health (NIMH) youth suicide prevention. pathway in primary care. Practices will receive 6 months of PF which involves clinic- and provider- level data review and adoption data for the 5 components of the prevention pathway, clinical coaching around implementing the different components , logistical coaching in identifying multilevel contextual barriers to implementation and strategies to overcome them
- Training in National Institute of Mental Health Youth Suicide Prevention Pathway
Intervention · OTHER
Training in the National Institute of Mental Health (NIMH) Youth Suicide Prevention Pathway involves a 2-hour in-person presentation created in consultation with NIMH, Zero Suicide and Substance Abuse and Mental Health Services Administration. It is delivered by a licensed professional counselor with content expertise to all primary care practice personnel involved in the prevention pathway. The first hour focuses on conducting Ask Suicide Screening Questions (ASQ) screening, identifying risk/protective factors, identifying warning signs and conducting a brief suicide safety assessment. The second hour covers safety planning, lethal means safety, behavioral health referrals and arranging follow-up. Didactic and interactive methods are used, including group discussion, activities, videos and case vignettes
Study details
- Sponsor
- University of Colorado, Denver
- Conditions
- Suicide Prevention
- Enrolling
- 360 people
- Starts
- 2024-10
- Est. completion
- 2027-03
- Design
- Double-blind, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 12 Years – 80 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Youth
- Between the ages of 12 and 24 years
- Present to a participating PCP and practice for a well visit
- Receive a positive ASQ screen during their well visit. Providers
- All staff in enrolled Primary Care practices (e.g., physicians, physician assistants nurses, administrative staff) will be eligible to participate and complete relevant measures.
You can't join if
- Youth
- Over 24 years
- Do not receive a positive ASQ screen at well visit.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openDepartment of Psychiatry, University of Colorado School of Medicine
Aurora, Colorado, United States
- Natalie Hazemi, MBA · Contact720-777-7849natalie.hazemi@childrenscolorado.org
- Vivian Thompson, MPH · Contact336-430-1662vivian.thonpson@cuanschutz.edu
- Bruno J Anthony, PhD · Principal investigator
Study team
Sponsor
University of Colorado, Denver
Study ID 23-2155
Principal investigator
Bruno J Anthony, PhD
University of Colorado School of Medicine - Anschutz Medical Campus
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.